Expression of SSR1 in pancreatic cancer

PANCREATIC ADENOCARCINOMA (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SSR1 is not prognostic in Pancreatic Adenocarcinoma (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 58.4

Median expressionⁱ : 50.54

Median follow up timeⁱ : 1.27

P scoreⁱ 0.026

5-year survival highⁱ 12%

5-year survival lowⁱ 38%

TCGA RNA samplesⁱ

Average pTPM

55.5

Number of samples

176

Samples

Sample	Description	pTPM
TCGA-3A-A9IO-01A	55 years, male, white, stage:'--, alive, 1942 days	171.1
TCGA-IB-7897-01A	53 years, female, white, stage:Stage IIB, dead, 486 days	128.2
TCGA-HZ-8005-01A	81 years, male, white, stage:Stage IIB, dead, 120 days	122.8
TCGA-HZ-8002-01A	61 years, male, white, stage:Stage IIB, dead, 366 days	121.8
TCGA-HZ-7922-01A	61 years, female, white, stage:Stage IIB, alive, 4 days	119.8
TCGA-F2-7273-01A	54 years, male, black or african american, stage:Stage IIB, dead, 592 days	115.8
TCGA-IB-7893-01A	64 years, male, white, stage:Stage IIA, dead, 117 days	115.3
TCGA-IB-7890-01A	73 years, male, stage:Stage IB, dead, 598 days	108.9
TCGA-HZ-7289-01A	77 years, male, white, stage:Stage IIB, dead, 661 days	106.0
TCGA-HZ-7924-01A	60 years, female, white, stage:Stage IIA, alive, 840 days	105.4
TCGA-HZ-7918-01A	72 years, male, white, stage:Stage IIB, alive, 969 days	103.4
TCGA-IB-7888-01A	66 years, female, black or african american, stage:Stage IIA, dead, 1332 days	103.1
TCGA-HZ-7920-01A	71 years, male, white, stage:Stage IB, dead, 236 days	101.2
TCGA-IB-7651-01A	64 years, female, white, stage:Stage IIB, dead, 603 days	101.1
TCGA-IB-7652-01A	49 years, female, asian, stage:Stage IIB, alive, 1116 days	100.2
TCGA-IB-7646-01A	60 years, male, white, stage:Stage IIB, dead, 145 days	92.5
TCGA-IB-7649-01A	73 years, female, stage:Stage IIB, dead, 467 days	92.4
TCGA-IB-7886-01A	80 years, male, white, stage:Stage IIB, dead, 123 days	91.3
TCGA-F2-7276-01A	64 years, male, white, stage:Stage IIB, dead, 216 days	90.7
TCGA-IB-7891-01A	49 years, female, white, stage:Stage IIB, dead, 913 days	90.0
TCGA-IB-7645-01A	44 years, female, stage:Stage IIB, dead, 1502 days	88.5
TCGA-3A-A9IZ-01A	47 years, male, white, stage:Stage IIB, dead, 308 days	87.3
TCGA-HZ-8636-01A	58 years, female, white, stage:Stage IV, dead, 545 days	85.3
TCGA-HZ-7925-01A	66 years, male, white, stage:Stage IIB, dead, 614 days	83.9
TCGA-HZ-7926-01A	57 years, male, black or african american, stage:Stage IIB, dead, 518 days	83.2
TCGA-IB-A5ST-01A	64 years, female, white, stage:Stage IIB, alive, 635 days	82.6
TCGA-L1-A7W4-01A	48 years, female, white, stage:Stage IIB, dead, 278 days	79.7
TCGA-IB-7644-01A	65 years, female, white, stage:Stage IV, dead, 394 days	79.5
TCGA-HZ-8638-01A	84 years, female, white, stage:Stage IA, dead, 151 days	77.7
TCGA-3A-A9IS-01A	67 years, male, white, stage:Stage IB, alive, 998 days	77.3
TCGA-2J-AABF-01A	73 years, male, white, stage:Stage IIB, dead, 691 days	76.8
TCGA-IB-7885-01A	78 years, female, white, stage:Stage IIB, alive, 1257 days	75.7
TCGA-IB-AAUP-01A	68 years, male, white, stage:Stage IIB, alive, 431 days	74.9
TCGA-H6-8124-01A	56 years, female, white, stage:Stage IIB, alive, 392 days	71.1
TCGA-IB-A7LX-01A	57 years, male, white, stage:Stage IIB, dead, 250 days	70.8
TCGA-HZ-8637-01A	76 years, female, white, stage:Stage IIB, dead, 517 days	70.8
TCGA-HZ-A4BH-01A	75 years, male, white, stage:Stage IIB, alive, 194 days	69.3
TCGA-IB-AAUS-01A	84 years, female, white, stage:Stage IIB, alive, 225 days	67.3
TCGA-2J-AAB8-01A	71 years, male, white, stage:Stage IIB, alive, 80 days	67.0
TCGA-IB-AAUW-01A	63 years, female, white, stage:Stage IIB, dead, 230 days	66.6
TCGA-IB-AAUV-01A	49 years, male, white, stage:Stage IIB, alive, 404 days	66.4
TCGA-3A-A9J0-01A	75 years, male, white, stage:Stage IIB, alive, 743 days	66.0
TCGA-2J-AABR-01A	60 years, female, white, stage:Stage IIA, alive, 438 days	65.9
TCGA-HZ-7923-01A	65 years, male, white, stage:Stage IIA, alive, 314 days	65.5
TCGA-S4-A8RO-01A	75 years, female, white, stage:Stage IIB, alive, 525 days	64.8
TCGA-Z5-AAPL-01A	74 years, female, white, stage:Stage IIA, alive, 467 days	64.4
TCGA-3A-A9IB-01A	69 years, female, white, stage:Stage IIB, dead, 224 days	63.9
TCGA-FB-A7DR-01A	48 years, male, asian, stage:Stage IIA, dead, 353 days	63.4
TCGA-IB-A5SS-01A	64 years, female, white, stage:Stage IIB, dead, 460 days	63.0
TCGA-3A-A9IR-01A	64 years, female, white, stage:Stage IB, alive, 1542 days	61.8
TCGA-IB-A5SQ-01A	56 years, female, white, stage:Stage IB, dead, 219 days	61.7
TCGA-RB-AA9M-01A	43 years, male, white, stage:Stage IIB, alive, 286 days	61.4
TCGA-2J-AABP-01A	58 years, female, white, stage:Stage IIB, alive, 463 days	61.2
TCGA-2J-AAB6-01A	75 years, male, white, stage:Stage IIA, dead, 293 days	60.4
TCGA-FB-AAPU-01A	41 years, female, asian, stage:Stage IIA, dead, 381 days	60.0
TCGA-HZ-8317-01A	69 years, female, white, stage:Stage IIB, dead, 378 days	59.8
TCGA-2L-AAQI-01A	66 years, male, white, stage:Stage IIB, dead, 103 days	59.6
TCGA-US-A77E-01A	73 years, male, white, stage:Stage IIB, dead, 430 days	59.5
TCGA-HZ-A8P1-01A	81 years, male, white, stage:Stage IB, alive, 7 days	59.4
TCGA-HZ-A77Q-01A	55 years, female, white, stage:Stage IIB, alive, 33 days	59.3
TCGA-IB-7654-01A	80 years, male, white, stage:Stage IIB, dead, 476 days	59.0
TCGA-IB-A5SO-01A	71 years, male, white, stage:Stage IIB, dead, 365 days	58.8
TCGA-US-A774-01A	76 years, female, white, stage:Stage IIB, dead, 695 days	58.5
TCGA-FB-AAPZ-01A	54 years, male, white, stage:Stage IIB, alive, 716 days	58.3
TCGA-YB-A89D-01A	59 years, male, white, stage:Stage IIB, alive, 350 days	57.5
TCGA-FB-A4P6-01A	54 years, male, white, stage:Stage IIB, alive, 767 days	57.3
TCGA-HZ-8519-01A	73 years, male, white, stage:Stage IA, alive, 454 days	57.2
TCGA-IB-8127-01A	59 years, male, white, stage:Stage IIB, alive, 522 days	57.2
TCGA-US-A776-01A	61 years, male, white, stage:Stage IIA, alive, 1216 days	57.1
TCGA-F2-A44G-01A	79 years, female, white, stage:Stage IIB, dead, 233 days	55.9
TCGA-FB-AAQ6-01A	85 years, male, white, stage:Stage IA, dead, 244 days	55.8
TCGA-HZ-A49G-01A	58 years, female, white, stage:Stage IIB, alive, 660 days	55.8
TCGA-IB-AAUQ-01A	50 years, male, white, stage:Stage IIB, dead, 183 days	55.5
TCGA-XD-AAUG-01A	66 years, female, white, stage:Stage IV, alive, 420 days	54.9
TCGA-HZ-7919-01A	52 years, female, white, stage:Stage IIB, dead, 593 days	54.6
TCGA-3A-A9I5-01A	57 years, male, white, stage:'--, alive, 1794 days	54.4
TCGA-3A-A9IX-01A	40 years, male, white, stage:Stage IA, alive, 1037 days	54.1
TCGA-HZ-A49I-01A	77 years, male, white, stage:Stage IIB, dead, 308 days	53.9
TCGA-S4-A8RP-01A	77 years, female, white, stage:Stage IIB, dead, 702 days	53.8
TCGA-IB-AAUT-01A	65 years, male, white, stage:Stage IIB, alive, 287 days	53.2
TCGA-IB-AAUR-01A	67 years, male, white, stage:Stage IIB, alive, 338 days	52.1
TCGA-HZ-A9TJ-01A	70 years, male, white, stage:Stage IV, alive, 603 days	52.0
TCGA-HV-A5A6-01A	65 years, female, asian, stage:Stage IIB, dead, 2036 days	51.6
TCGA-F2-6879-01A	57 years, male, white, stage:Stage IIB, dead, 334 days	51.5
TCGA-YH-A8SY-01A	73 years, female, white, stage:'--, alive, 388 days	51.4
TCGA-HV-A5A4-01A	72 years, female, asian, stage:Stage IIA, alive, 232 days	50.8
TCGA-HZ-8315-01A	54 years, female, white, stage:Stage IIA, dead, 299 days	50.8
TCGA-3A-A9IC-01A	61 years, female, white, stage:Stage IIB, dead, 738 days	50.6
TCGA-IB-7887-01A	62 years, female, white, stage:Stage IIB, dead, 110 days	50.5
TCGA-FB-AAPS-01A	62 years, female, white, stage:Stage IIB, alive, 228 days	50.0
TCGA-2J-AABO-01A	43 years, male, white, stage:Stage IIB, alive, 440 days	49.8
TCGA-XD-AAUL-01A	56 years, male, white, stage:Stage IIA, alive, 498 days	49.6
TCGA-3A-A9IU-01A	65 years, male, white, stage:Stage IIB, dead, 458 days	49.3
TCGA-F2-A7TX-01A	77 years, male, white, stage:Stage IIB, dead, 95 days	48.9
TCGA-HZ-8003-01A	65 years, female, white, stage:Stage IIB, dead, 596 days	48.1
TCGA-M8-A5N4-01A	48 years, female, stage:Stage IIA, alive, 584 days	47.8
TCGA-2J-AAB9-01A	70 years, female, white, stage:Stage IIB, dead, 627 days	47.7
TCGA-IB-A7M4-01A	81 years, male, white, stage:Stage IIB, alive, 483 days	47.5
TCGA-2J-AABT-01A	72 years, female, white, stage:Stage IIB, alive, 319 days	46.9
TCGA-FB-AAPP-01A	71 years, male, white, stage:Stage IIB, dead, 485 days	46.7
TCGA-3A-A9I7-01A	45 years, male, black or african american, stage:Stage IIB, alive, 1323 days	46.6
TCGA-H6-A45N-01A	88 years, female, white, stage:Stage IIB, dead, 397 days	46.5
TCGA-XD-AAUH-01A	57 years, female, white, stage:Stage IIB, alive, 395 days	46.4
TCGA-IB-A6UF-01A	63 years, male, white, stage:Stage IIB, alive, 666 days	46.3
TCGA-2J-AAB4-01A	48 years, male, white, stage:Stage IIB, alive, 729 days	45.5
TCGA-F2-A44H-01A	65 years, male, white, stage:Stage IIA, alive, 586 days	45.4
TCGA-2J-AABU-01A	56 years, male, white, stage:Stage IIB, dead, 277 days	45.2
TCGA-IB-AAUU-01A	35 years, male, white, stage:Stage IIB, alive, 245 days	45.1
TCGA-HZ-8001-01A	69 years, male, white, stage:Stage III, alive, 706 days	44.8
TCGA-HV-AA8V-01A	50 years, male, asian, stage:Stage IIB, alive, 920 days	44.8
TCGA-XN-A8T3-01A	67 years, male, white, stage:Stage IB, alive, 951 days	44.7
TCGA-3E-AAAY-01A	67 years, male, white, stage:Stage IIB, alive, 2285 days	44.6
TCGA-HV-A5A5-01A	61 years, female, asian, stage:Stage IIB, alive, 289 days	44.1
TCGA-2L-AAQJ-01A	49 years, female, white, stage:Stage III, dead, 394 days	44.0
TCGA-LB-A8F3-01A	64 years, female, black or african american, stage:Stage IIA, alive, 379 days	43.3
TCGA-2J-AABE-01A	73 years, male, white, stage:Stage IIA, alive, 676 days	42.8
TCGA-FB-AAQ1-01A	49 years, male, white, stage:Stage IIB, dead, 123 days	42.5
TCGA-XD-AAUI-01A	50 years, female, white, stage:Stage IIB, dead, 366 days	42.3
TCGA-3A-A9IV-01A	59 years, female, white, stage:Stage IB, alive, 1103 days	41.8
TCGA-HZ-A4BK-01A	72 years, male, white, stage:Stage IIB, alive, 657 days	41.3
TCGA-RB-A7B8-01A	81 years, female, white, stage:Stage IIB, dead, 466 days	41.2
TCGA-F2-A8YN-01A	76 years, male, white, stage:Stage IIA, alive, 517 days	40.7
TCGA-XN-A8T5-01A	53 years, female, white, stage:Stage IB, alive, 720 days	40.6
TCGA-HZ-A77P-01A	77 years, male, white, stage:Stage IIB, alive, 330 days	40.6
TCGA-FB-A4P5-01A	69 years, female, white, stage:Stage IIB, dead, 179 days	40.5
TCGA-RL-AAAS-01A	60 years, female, white, stage:Stage IB, alive, 9 days	40.3
TCGA-FB-AAPQ-01A	65 years, male, white, stage:Stage IIB, dead, 1130 days	39.1
TCGA-HZ-A77O-01A	77 years, female, white, stage:Stage IIB, dead, 160 days	38.5
TCGA-3A-A9IH-01A	66 years, female, white, stage:Stage IA, alive, 1021 days	38.2
TCGA-H8-A6C1-01A	53 years, male, white, stage:Stage IIA, alive, 671 days	38.0
TCGA-3E-AAAZ-01A	71 years, male, white, stage:Stage IIA, dead, 2182 days	37.8
TCGA-FB-AAQ0-01A	68 years, male, white, stage:Stage IIA, dead, 473 days	37.6
TCGA-S4-A8RM-01A	67 years, male, white, stage:Stage IIB, alive, 737 days	37.5
TCGA-FB-A78T-01A	71 years, female, white, stage:Stage IIB, dead, 375 days	37.5
TCGA-FB-AAQ2-01A	81 years, female, white, stage:Stage IIB, dead, 153 days	37.4
TCGA-2J-AABH-01A	61 years, male, white, stage:Stage IIA, alive, 1287 days	37.4
TCGA-2J-AABA-01A	55 years, male, white, stage:Stage IIB, dead, 607 days	37.1
TCGA-2L-AAQA-01A	76 years, male, white, stage:Stage IIB, dead, 143 days	36.9
TCGA-2J-AABK-01A	71 years, male, white, stage:Stage IIB, alive, 484 days	36.8
TCGA-IB-AAUN-01A	74 years, female, white, stage:Stage IB, dead, 144 days	36.7
TCGA-2J-AAB1-01A	65 years, male, white, stage:Stage IIB, dead, 66 days	36.6
TCGA-HV-AA8X-01A	75 years, female, asian, stage:Stage IIB, dead, 532 days	36.5
TCGA-HZ-A49H-01A	68 years, female, white, stage:Stage IIB, alive, 491 days	36.3
TCGA-IB-AAUO-01A	64 years, female, white, stage:Stage IIB, dead, 239 days	35.8
TCGA-LB-A9Q5-01A	63 years, female, white, stage:Stage IIB, dead, 313 days	35.2
TCGA-FB-A545-01A	72 years, female, white, stage:Stage IIB, dead, 732 days	34.8
TCGA-2L-AAQM-01A	52 years, male, white, stage:Stage IIB, alive, 1383 days	34.7
TCGA-LB-A7SX-01A	74 years, female, black or african american, stage:Stage IIB, dead, 393 days	34.7
TCGA-US-A77J-01A	81 years, female, white, stage:Stage IIB, dead, 568 days	34.6
TCGA-FB-A5VM-01A	74 years, male, white, stage:Stage IB, dead, 498 days	34.5
TCGA-IB-7889-01A	85 years, female, white, stage:Stage IIB, dead, 481 days	34.5
TCGA-Q3-A5QY-01A	58 years, male, white, stage:Stage IIB, alive, 416 days	34.1
TCGA-PZ-A5RE-01A	44 years, female, white, stage:Stage IIB, dead, 470 days	32.3
TCGA-2L-AAQE-01A	56 years, male, white, stage:Stage IIB, dead, 684 days	32.1
TCGA-3A-A9IN-01A	62 years, female, white, stage:Stage IB, alive, 2084 days	31.7
TCGA-IB-8126-01A	79 years, female, white, stage:Stage III, alive, 462 days	31.6
TCGA-3A-A9IJ-01A	65 years, male, white, stage:Stage IB, alive, 1854 days	30.1
TCGA-3A-A9IL-01A	39 years, female, white, stage:Stage I, alive, 2741 days	29.4
TCGA-IB-AAUM-01A	76 years, male, white, stage:Stage IIB, alive, 8 days	29.2
TCGA-IB-A6UG-01A	65 years, male, white, stage:Stage IIB, dead, 41 days	29.0
TCGA-FB-AAPY-01A	71 years, male, white, stage:Stage IIB, dead, 1059 days	28.7
TCGA-US-A77G-01A	64 years, male, white, stage:Stage IIB, dead, 12 days	28.4
TCGA-3A-A9I9-01A	67 years, male, white, stage:Stage IIA, dead, 634 days	28.2
TCGA-IB-A5SP-01A	77 years, male, white, stage:Stage IIA, alive, 482 days	27.6
TCGA-FB-AAQ3-01A	65 years, female, white, stage:Stage IIB, dead, 31 days	27.3
TCGA-2L-AAQL-01A	82 years, male, white, stage:Stage IIB, dead, 292 days	26.8
TCGA-Q3-AA2A-01A	64 years, female, white, stage:Stage IB, alive, 95 days	26.6
TCGA-2J-AABI-01A	55 years, female, white, stage:Stage IIA, alive, 969 days	26.0
TCGA-YY-A8LH-01A	61 years, female, white, stage:Stage IIB, alive, 2016 days	25.0
TCGA-OE-A75W-01A	75 years, male, white, stage:Stage IIA, dead, 267 days	23.3
TCGA-HV-A5A3-01A	50 years, male, asian, stage:Stage IIA, dead, 128 days	22.5
TCGA-US-A779-01A	54 years, female, white, stage:Stage IIB, dead, 511 days	21.6
TCGA-F2-6880-01A	70 years, male, white, stage:Stage IIB, alive, 295 days	19.3
TCGA-HV-A7OP-01A	72 years, male, asian, stage:Stage IIB, alive, 978 days	16.9
TCGA-HV-A7OL-01A	70 years, male, asian, stage:Stage IIA, alive, 252 days	16.8
TCGA-2J-AABV-01A	74 years, male, white, stage:Stage IIB, dead, 652 days	10.9
Show allShow less

PANCREATIC ADENOCARCINOMA (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SSR1 is not prognostic in Pancreatic Adenocarcinoma (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 92.9

Median expressionⁱ : 95.39

Median follow up timeⁱ : 1.15

P scoreⁱ 0.15

5-year survival highⁱ 0%

5-year survival lowⁱ 11%

TCGA RNA samplesⁱ

Average pTPM

96.3

Number of samples

Samples

Sample	Description	pTPM
DO32863	60 years, male, NA, stage:, dead, 715 days	176.7
DO34448	79 years, female, NA, stage:, dead, 719 days	166.4
DO33128	72 years, male, NA, stage:, dead, 423 days	156.4
DO33472	75 years, female, NA, stage:, dead, 388 days	148.9
DO49138	74 years, male, NA, stage:, dead, 230 days	144.9
DO33368	81 years, male, NA, stage:, dead, 98 days	139.4
DO34720	68 years, male, NA, stage:, alive, 555 days	136.6
DO49080	60 years, male, NA, stage:, alive, 83 days	131.2
DO33344	70 years, male, NA, stage:, dead, 361 days	127.2
DO49129	50 years, male, NA, stage:, alive, 337 days	127.1
DO33392	70 years, male, NA, stage:, alive, 1014 days	125.9
DO49087	68 years, female, NA, stage:, dead, 260 days	125.8
DO49079	50 years, male, NA, stage:, dead, 332 days	124.9
DO49172	60 years, female, NA, stage:, dead, 1021 days	121.7
DO49130	76 years, female, NA, stage:, alive, 351 days	119.0
DO33400	76 years, female, NA, stage:, alive, 1043 days	118.7
DO33544	83 years, female, NA, stage:, dead, 412 days	116.0
DO33552	70 years, female, NA, stage:, alive, 873 days	115.4
DO33336	67 years, female, NA, stage:, dead, 451 days	115.0
DO49137	67 years, female, NA, stage:, alive, 232 days	114.7
DO34696	75 years, male, NA, stage:, alive, 689 days	113.9
DO33984	64 years, male, NA, stage:, alive, 847 days	113.4
DO33376	62 years, female, NA, stage:, alive, 909 days	112.9
DO34801	60 years, male, NA, stage:, alive, 626 days	111.8
DO34905	64 years, male, NA, stage:, alive, 1142 days	109.3
DO34608	72 years, female, NA, stage:, dead, 709 days	109.3
DO34961	71 years, male, NA, stage:, dead, 632 days	106.1
DO34368	64 years, female, NA, stage:, dead, 537 days	105.9
DO32875	69 years, male, NA, stage:, dead, 348 days	104.2
DO33512	female, NA, stage:, dead, 499 days	104.1
DO34849	86 years, female, NA, stage:, dead, 272 days	102.7
DO33488	61 years, male, NA, stage:, alive, 844 days	102.2
DO34600	77 years, male, NA, stage:, dead, 537 days	101.9
DO34793	56 years, male, NA, stage:, dead, 427 days	101.7
DO49185	55 years, male, NA, stage:, alive, 179 days	101.7
DO34504	37 years, male, NA, stage:, dead, 257 days	101.0
DO34240	72 years, male, NA, stage:, dead, 236 days	100.2
DO32878	69 years, female, NA, stage:, dead, 260 days	100.2
DO49170	67 years, male, NA, stage:, alive, 197 days	99.0
DO49204	67 years, male, NA, stage:, dead, 156 days	96.3
DO34809	74 years, female, NA, stage:, dead, 297 days	94.4
DO32900	51 years, male, NA, stage:, dead, 768 days	94.3
DO49090	77 years, female, NA, stage:, dead, 152 days	94.3
DO34288	83 years, female, NA, stage:, dead, 220 days	93.1
DO49076	64 years, male, NA, stage:, dead, 480 days	92.9
DO32829	78 years, female, NA, stage:T2N0MX, dead, 1874 days	90.7
DO49184	56 years, male, NA, stage:, dead, 455 days	89.6
DO34656	61 years, female, NA, stage:, alive, 834 days	89.6
DO49078	79 years, male, NA, stage:, dead, 465 days	89.3
DO33480	52 years, male, NA, stage:, alive, 1054 days	89.0
DO34680	75 years, male, NA, stage:, dead, 99 days	88.7
DO34728	77 years, female, NA, stage:, alive, 508 days	87.6
DO49133	55 years, female, NA, stage:, alive, 188 days	87.2
DO34640	49 years, female, NA, stage:, dead, 287 days	85.8
DO49178	58 years, male, NA, stage:, dead, 27 days	84.8
DO34817	72 years, female, NA, stage:, alive, 540 days	84.5
DO49113	46 years, female, NA, stage:, alive, 413 days	84.3
DO49166	40 years, female, NA, stage:, alive, 222 days	83.0
DO49183	51 years, female, NA, stage:, dead, 429 days	82.4
DO49164	70 years, male, NA, stage:, alive, 272 days	79.7
DO34736	78 years, female, NA, stage:, dead, 203 days	77.6
DO34616	68 years, female, NA, stage:, alive, 666 days	76.7
DO34312	58 years, female, NA, stage:, dead, 226 days	75.0
DO33168	80 years, female, NA, stage:, dead, 8 days	73.5
DO33600	77 years, female, NA, stage:, alive, 854 days	72.8
DO49181	77 years, male, NA, stage:, dead, 1534 days	71.0
DO49168	58 years, male, NA, stage:, alive, 149 days	69.1
DO49198	61 years, female, NA, stage:, dead, 251 days	66.5
DO49135	65 years, male, NA, stage:, alive, 270 days	66.5
DO34264	63 years, female, NA, stage:, dead, 1144 days	66.1
DO33408	68 years, female, NA, stage:, alive, 909 days	66.1
DO49193	60 years, male, NA, stage:, dead, 1 days	62.5
DO49127	77 years, female, NA, stage:, alive, 392 days	61.4
DO34432	82 years, female, NA, stage:, dead, 400 days	59.6
DO32860	57 years, male, NA, stage:, dead, 1259 days	59.5
DO34785	67 years, female, NA, stage:, alive, 721 days	51.0
DO49199	52 years, male, NA, stage:, dead, 1095 days	49.5
DO49175	68 years, male, NA, stage:, dead, 414 days	45.1
DO49074	49 years, male, NA, stage:, dead, 168 days	21.2
DO34336	70 years, female, NA, stage:, alive, 743 days	4.4
Show allShow less

PANCREATIC DUCTAL ADENOCARCINOMA - Protein relative expression (CPTAC)

Number of samples

235

Samples

Sample ID	Sample type	nRPX
CPT0089750004	Normal	2.2
CPT0063580003	Normal	2.0
CPT0091680003	Normal	2.0
CPT0017130003	Normal	1.9
CPT0170260004	Normal	1.8
CPT0127290003	Normal	1.8
CPT0238740004	Normal	1.8
CPT0078180003	Normal	1.7
CPT0025760003	Normal	1.7
CPT0208850004	Normal	1.6
CPT0218220004	Normal	1.6
CPT0347820002	Normal	1.5
CPT0239920004	Normal	1.5
CPT0237850004	Normal	1.5
CPT0236800004	Normal	1.5
CPT0183770004	Normal	1.4
CPT0238640004	Normal	1.4
CPT0236710004	Normal	1.4
CPT0209650004	Normal	1.4
CPT0236360004	Normal	1.4
CPT0077810003	Normal	1.4
CPT0198930003	Normal	1.3
CPT0123890003	Normal	1.3
C3L-00189-04	Normal	1.3
CPT0237920004	Normal	1.3
CPT0077950003	Normal	1.3
CPT0125010003	Normal	1.2
CPT0238940004	Normal	1.2
CPT0355190003	Normal	1.2
CPT0347880002	Normal	1.2
CPT0123460003	Normal	1.1
CPT0347760002	Normal	1.1
C3L-03632-04	Normal	1.1
CPT0208710004	Normal	1.1
CPT0166780004	Normal	1.1
C3N-02573-03	Normal	1.1
CPT0239140004	Normal	1.1
CPT0123670003	Normal	1.0
C3N-00709-06	Normal	1.0
CPT0198440004	Normal	1.0
CPT0347850002	Normal	1.0
CPT0276030003	Normal	1.0
CPT0162780004	Normal	0.9
CPT0187540004	Normal	0.8
CPT0123770003	Normal	0.8
CPT0108960003	Normal	0.8
CPT0246220004	Normal	0.7
CPT0355200003	Normal	0.7
CPT0093860003	Tumor	0.7
CPT0248440003	Normal	0.7
CPT0246950003	Normal	0.6
CPT0247090003	Tumor	0.6
CPT0347790002	Normal	0.5
CPT0093880003	Normal	0.5
CPT0011540003	Normal	0.5
CPT0221250004	Normal	0.3
CPT0077880003	Normal	0.3
CPT0066020003	Normal	0.3
CPT0123650003	Tumor	0.3
CPT0247000003	Normal	0.2
CPT0094180003	Tumor	0.2
CPT0124530003	Normal	0.1
CPT0124000003	Normal	0.1
CPT0077790004	Tumor	0.1
CPT0139000004	Tumor	0.0
CPT0123750003	Tumor	0.0
CPT0094030003	Tumor	-0.1
CPT0092630003	Tumor	-0.1
CPT0246810003	Tumor	-0.1
CPT0123860003	Tumor	-0.1
CPT0162670004	Normal	-0.2
KoreanReference2	Tumor	-0.2
CPT0207990004	Normal	-0.2
CPT0017040004	Tumor	-0.2
CPT0248620003	Normal	-0.2
CPT0246210004	Tumor	-0.2
CPT0094130004	Tumor	-0.2
CPT0236560004	Tumor	-0.2
KoreanReference3	Tumor	-0.3
CPT0086210003	Normal	-0.3
KoreanReference1	Tumor	-0.4
CPT0221470005	Tumor	-0.4
CPT0086190004	Tumor	-0.4
CPT0238920004	Tumor	-0.4
CPT0078160004	Tumor	-0.4
CPT0162760003	Tumor	-0.4
CPT0238820005	Tumor	-0.4
CPT0248590004	Tumor	-0.5
CPT0254680003	Tumor	-0.5
WU-PDA1	Tumor	-0.5
CPT0127270003	Tumor	-0.5
CPT0093980004	Tumor	-0.5
CPT0063970004	Tumor	-0.5
CPT0226570004	Tumor	-0.5
CPT0207980005	Tumor	-0.5
CPT0011520003	Tumor	-0.5
CPT0246840003	Tumor	-0.5
CPT0108930003	Tumor	-0.5
CPT0081060004	Tumor	-0.5
CPT0064110003	Normal	-0.5
CPT0162660004	Tumor	-0.5
CPT0108400003	Tumor	-0.5
CPT0081260004	Tumor	-0.5
CPT0077930004	Tumor	-0.5
CPT0207780004	Tumor	-0.5
CPT0063570003	Tumor	-0.5
CPT0226530004	Tumor	-0.6
CPT0246720003	Tumor	-0.6
CPT0088180004	Tumor	-0.6
CPT0247040003	Tumor	-0.6
CPT0248410004	Tumor	-0.6
CPT0355180003	Normal	-0.6
CPT0078090004	Tumor	-0.6
CPT0236780005	Tumor	-0.6
CPT0123990003	Tumor	-0.6
CPT0065640003	Tumor	-0.6
CPT0208840004	Tumor	-0.6
CPT0238440005	Tumor	-0.6
CPT0109010004	Tumor	-0.6
CPT0187930005	Tumor	-0.6
CPT0241320005	Tumor	-0.6
CPT0094230004	Tumor	-0.6
CPT0124410004	Tumor	-0.6
CPT0025750003	Tumor	-0.6
CPT0088320003	Tumor	-0.6
CPT0239910004	Tumor	-0.6
CPT0221240004	Tumor	-0.6
CPT0246990003	Tumor	-0.6
CPT0138990003	Normal	-0.6
CPT0125130003	Tumor	-0.6
CPT0087890004	Tumor	-0.6
CPT0124360003	Tumor	-0.7
CPT0094630004	Tumor	-0.7
CPT0001750003	Normal	-0.7
CPT0124610004	Tumor	-0.7
CPT0236700005	Tumor	-0.7
CPT0209310004	Tumor	-0.7
CPT0125090003	Tumor	-0.7
CPT0019410004	Tumor	-0.7
CPT0109300004	Tumor	-0.7
CPT0088260004	Tumor	-0.7
CPT0077860003	Tumor	-0.7
CPT0237910004	Tumor	-0.7
CPT0166760004	Tumor	-0.7
CPT0014040003	Tumor	-0.7
CPT0083270003	Tumor	-0.7
CPT0094740004	Tumor	-0.7
CPT0081470004	Tumor	-0.7
CPT0246940003	Tumor	-0.7
CPT0226760004	Tumor	-0.7
CPT0078000003	Tumor	-0.8
CPT0217700004	Tumor	-0.8
CPT0174800003	Normal	-0.8
CPT0109200004	Tumor	-0.8
CPT0237840004	Tumor	-0.8
CPT0226650004	Tumor	-0.8
CPT0186040004	Tumor	-0.8
CPT0238610009	Tumor	-0.8
CPT0236340004	Tumor	-0.8
CPT0226680005	Tumor	-0.8
CPT0208550005	Tumor	-0.8
CPT0238040005	Tumor	-0.8
CPT0238710004	Tumor	-0.8
CPT0081360004	Tumor	-0.8
CPT0246260004	Tumor	-0.8
CPT0185920004	Tumor	-0.8
CPT0124500004	Tumor	-0.8
CPT0078250003	Tumor	-0.8
CPT0276010003	Tumor	-0.8
CPT0064090003	Tumor	-0.8
CPT0064520004	Tumor	-0.8
CPT0187550004	Tumor	-0.8
CPT0198910005	Tumor	-0.9
CPT0174700004	Tumor	-0.9
CPT0161990005	Tumor	-0.9
CPT0065570003	Tumor	-0.9
CPT0091660003	Tumor	-0.9
CPT0218200004	Tumor	-0.9
CPT0264150003	Tumor	-0.9
CPT0000250017	Tumor	-0.9
CPT0226610004	Normal	-0.9
CPT0208690004	Tumor	-0.9
CPT0183450005	Tumor	-0.9
CPT0197420004	Tumor	-0.9
CPT0123440003	Tumor	-0.9
CPT0089720003	Tumor	-0.9
CPT0197440004	Normal	-0.9
CPT0227930004	Tumor	-1.0
CPT0001730017	Tumor	-1.0
CPT0235230004	Tumor	-1.0
CPT0064570003	Normal	-1.0
CPT0241500004	Tumor	-1.0
CPT0224460004	Tumor	-1.0
CPT0093930004	Tumor	-1.0
CPT0019300004	Tumor	-1.0
CPT0226600004	Tumor	-1.0
CPT0078030003	Normal	-1.1
CPT0209640005	Tumor	-1.1
CPT0170240004	Tumor	-1.1
C3L-00401-04	Normal	-1.1
CPT0198420004	Tumor	-1.1
CPT0237270005	Tumor	-1.1
CPT0126160004	Tumor	-1.1
CPT0238530005	Tumor	-1.2
CPT0198700005	Tumor	-1.2
CPT0124980004	Tumor	-1.3
CPT0008800003	Tumor	-1.3
CPT0203850004	Tumor	-1.3
CPT0094940004	Tumor	-1.3
CPT0226490004	Tumor	-1.3
CPT0008750003	Tumor	-1.4
CPT0241510004	Normal	-1.4
CPT0183750005	Tumor	-1.5
CPT0239100009	Tumor	-1.5
CPT0161770004	Tumor	-1.7
CPT0247050003	Normal	N/A
CPT0108410003	Normal	N/A
CPT0248320003	Normal	N/A
CPT0166650006	Tumor	N/A
CPT0224470004	Normal	N/A
C3L-01687-04	Normal	N/A
CPT0138890003	Normal	N/A
CPT0109110004	Tumor	N/A
WU-pooled sample	Tumor	N/A
CPT0014060003	Normal	N/A
CPT0109130003	Normal	N/A
CPT0138900004	Tumor	N/A
CPT0166680004	Normal	N/A
CPT0094760003	Normal	N/A
CPT0186050004	Normal	N/A
CPT0237290004	Normal	N/A
CPT0264180003	Normal	N/A
CPT0063990003	Normal	N/A
CPT0126200003	Normal	N/A
CPT0198730004	Normal	N/A
Show allShow less

PANCREATIC CANCER - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample. Ascending and descending describe two types of gradient, based on difference in staining intensity between enterocytes in crypts and apical enterocytes. Ascending - the staining intensity is stronger in apical enterocytes (towards the lumen) compared to enterocytes in the crypts (gland based) Descending - the staining is weaker in apical enterocytes compared to enterocytes in crypts	Antibody HPA011276	Antibody HPA017062
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Adenocarcinoma, NOS

Adenocarcinoma, NOS Adenocarcinoma, metastatic, NOS